Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian, U.K. Firms To Join In Creating Early Alzheimer’s Test

This article was originally published in PharmAsia News

Executive Summary

Australia's Alzhyme Pty and Senexis of the United Kingdom have signed an agreement to work on discovering a new way to diagnose Alzheimer's disease. Such a test would be a first for a disease that usually begins years before clinical symptoms are observed. The collaboration is aimed at developing a diagnostic test kit reliable and inexpensive enough to allow routine detection of biomarkers in the blood. The two companies see a $1 billion global market for such a test as the number of cases doubles over the next two decades. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067377

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel